This inventor holds 1 USPTO granted patent. Top assignee: Yeungnam University. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Bum-Ho Bin: Innovator in Cellular Senescence Treatment
Introduction
Bum-Ho Bin is a notable inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of cellular senescence and its associated diseases. His innovative work focuses on developing compositions that can prevent or treat various age-related conditions.
Latest Patents
Bum-Ho Bin holds a patent for a composition aimed at preventing or treating cellular senescence-associated diseases. This composition contains homoharringtonine as its active ingredient. The invention demonstrates a senolytic effect, selectively targeting aging-induced fibroblasts and renal tubular cells. It also exhibits a senomorphic effect, restoring the function and morphology of cells. This dual action allows for effective prevention and treatment of conditions such as senile eye disease, tissue fibrosis, atherosclerosis, osteoarthritis, degenerative brain disease, chronic skin damage, obesity, and diabetes. The composition can also be utilized for skin whitening and life extension.
Career Highlights
Bum-Ho Bin is affiliated with the Research Cooperation Foundation of Yeungnam University. His work has garnered attention for its potential impact on aging-related health issues. He has dedicated his career to exploring innovative solutions that address the challenges posed by cellular aging.
Collaborations
Bum-Ho Bin collaborates with esteemed colleagues, including Jae-Ryong Kim and Eok-Cheon Kim. Their combined expertise enhances the research and development of effective treatments for cellular senescence-associated diseases.
Conclusion
Bum-Ho Bin's contributions to the field of cellular senescence are noteworthy. His innovative patent offers promising solutions for age-related diseases, showcasing the potential of homoharringtonine in medical applications. His work continues to inspire advancements in the treatment of aging-related conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile